AK Medical to Convene 26 Aug 2026 Board Meeting for H1 Results and Interim Dividend Review

Bulletin Express

Aug 14

AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and deliberation on the declaration of an interim dividend.

The meeting will be chaired by Chairman Li Zhijiang and attended by the full Board, comprising four executive Directors (Li Zhijiang, Zhang Bin, Zhang Chaoyang, Zhao Xiaohong), one non-executive Director (Dr. Wang David Guowei) and three independent non-executive Directors (Kong Chi Mo, Dr. Li Shu Wing David, Dr. Gao Wei).

The company’s announcement, released on 14 August 2026, emphasizes that any interim dividend decision will be contingent upon the Board’s review of the half-year financial performance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1184965148"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1184965148\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1184965148?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 08:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184965148","market":"us","top_or_hot":-1,"title":"AK Medical to Convene 26 Aug 2026 Board Meeting for H1 Results and Interim Dividend Review","media":"Bulletin Express","content":"<p>AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and deliberation on the declaration of an interim dividend.</p>\n<p>The meeting will be chaired by Chairman Li Zhijiang and attended by the full Board, comprising four executive Directors (Li Zhijiang, Zhang Bin, Zhang Chaoyang, Zhao Xiaohong), one non-executive Director (Dr. Wang David Guowei) and three independent non-executive Directors (Kong Chi Mo, Dr. Li Shu Wing David, Dr. Gao Wei).</p>\n<p>The company’s announcement, released on 14 August 2026, emphasizes that any interim dividend decision will be contingent upon the Board’s review of the half-year financial performance.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AK Medical to Convene 26 Aug 2026 Board Meeting for H1 Results and Interim Dividend Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAK Medical to Convene 26 Aug 2026 Board Meeting for H1 Results and Interim Dividend Review\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-14 08:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and deliberation on the declaration of an interim dividend.</p>\n<p>The meeting will be chaired by Chairman Li Zhijiang and attended by the full Board, comprising four executive Directors (Li Zhijiang, Zhang Bin, Zhang Chaoyang, Zhao Xiaohong), one non-executive Director (Dr. Wang David Guowei) and three independent non-executive Directors (Kong Chi Mo, Dr. Li Shu Wing David, Dr. Gao Wei).</p>\n<p>The company’s announcement, released on 14 August 2026, emphasizes that any interim dividend decision will be contingent upon the Board’s review of the half-year financial performance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01789","symbol_name":"爱康医疗","start_time":0,"source_url":"","article_id":"1184965148","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184965148","pubTimestamp":1786665954,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01789":"爱康医疗"},"translate_title":"AK Medical 将于 2026 年 8 月 26 日召开董事会会议，审查上半年业绩和中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01789":1},"content_text":"AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and deliberation on the declaration of an interim dividend.\nThe meeting will be chaired by Chairman Li Zhijiang and attended by the full Board, comprising four executive Directors (Li Zhijiang, Zhang Bin, Zhang Chaoyang, Zhao Xiaohong), one non-executive Director (Dr. Wang David Guowei) and three independent non-executive Directors (Kong Chi Mo, Dr. Li Shu Wing David, Dr. Gao Wei).\nThe company’s announcement, released on 14 August 2026, emphasizes that any interim dividend decision will be contingent upon the Board’s review of the half-year financial performance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}